Pathological myopia can induce choroidal neovascularization (PM-CNV). The potential risk factors include ageing, long axial length of the eyeball, thinning of subfoveal choroidal thickness, fundus atrophy spot and lacquer crack. These factors may induce atrophy of retinal pigment epithelial cells (RPE) and hypoxia, resulting in vascular endothelial growth factors (VEGF) secretion by outer retina. The lesion type, location and activity of PM-CNV can be determined by fundus fluorescein angiography. The features of PM-CNV on optical coherence tomography include strong reflective area close to RPE with very small amount of subretinal fluid (active stage), surface strong reflection with signal attenuation area (scar stage) and flat lesion and chorioretinal atrophy (atrophy stage). Photodynamic therapy and intravitreal injection of anti-VEGF drugs are major treatments for PM-CNV, the latter is more commonly used now. However, more large randomized controlled studies are required to explore the treatment regimen (such as frequency, indications for repeated or termination of treatment) and the efficacy factors further.
Pachychoroid spectrum diseases includes central serous chorioretinopathy (CSC), pachychoroid pigment epitheliopathy, pachychoroid neovasculopathy, and polypoidal choroidal vasculopathy, which share common characteristics, including focal or diffused increased choroidal thickness, choroidal hyper-permeability, and dilated choroidal vessels. These diseases are likely to represent a continuum of the same pathogenic process. Similar features and association among them suggest that they may have similar etiology. It is of great clinical significance to understand the composition and typical morphological changes of pachychoroid-related diseases and to explore its possible pathogenesis.
As a new and non-invasive imaging technology, optical coherence tomography angiography (OCTA) has been using in ocular fundus diseases, glaucoma and neuro-ophthalmic disorders for more than 4 years. The most valuable and efficient application of OCTA is in detecting neovascular diseases in the macula. The big advantage of OCTA is for diagnosing all kinds of choroidal neovascularization. OCTA can observe blood flow information in different layers of the retina. To a large extent, it changes our diagnostic thinking and pathway in macular diseases. Before acquiring OCTA image, the operator should be well trained to ensure to get high quality images with good signal strength and less artifact. OCTA report should show the segmentation slab that the ophthalmologist wants to see. So far, OCTA has difficulty to reach peripheral retina with default setting. Even so, OCTA has provided much information of blood flow within retinal vascular arcade for evaluating structural and functional changes. We are expecting that the swept source OCTA could give us better observation of the choroidal blood flow. That should be the breakthrough of the new generation of OCTA.